论文部分内容阅读
2011年,正大集团斥资1.2亿元,在江苏邳州建设了一家现代化、高标准的兽药制剂生产企业——邳州正康生物技术有限公司;2012年10月,正大集团又注册成立了正大联合动物制药科技(江苏)有限公司(以下简称“正大联合动物制药”),作为其在中国投资的唯一一家集研发、生产、销售服务、国际贸易为一体的兽药生产经营公司;2013年6月,正大联合动物制药开始试生产,并于7月正式对外销售产品。截至目前,正大联合动物制药拥有水针剂、粉针剂、口服液、可溶性粉和预混剂5条自动
In 2011, Chia Tai Group invested 120 million yuan to build a modern and high-standard veterinary drug manufacturer in Danzhou - Danzhou Zhengkang Biotechnology Co., Ltd. In October 2012, Chia Tai Group also incorporated Chia Tai Alliance Animal Pharmaceutical Technology (Jiangsu) Co., Ltd. (hereinafter referred to as “Zhengda United Animal Pharmaceuticals”) as its only veterinary drug production and operation company in China that invests in R & D, production, sales and service and international trade. In June 2013, Zhengda United Animal Pharmaceutical began trial production, and in July officially sold products. Up to now, Chia Tai Alliance animal pharmaceuticals have water injection, injection, oral solution, soluble powder and premix 5 automatic